Cancer immunotherapy: exploiting neoepitopes

被引：16
|
作者：
Platten, Michael [1 ,2 ,3 ]
Offringa, Rienk [4 ,5 ]
机构：
[1] German Canc Res Ctr, DKTK Clin Cooperat Unit Neuroimmunol & Brain Tumo, Heidelberg, Germany
[2] Univ Heidelberg Hosp, Neurol Clin, Heidelberg, Germany
[3] Natl Ctr Tumor Dis, Heidelberg, Germany
[4] German Canc Res Ctr, Dept Mol Oncol Gastrointestinal Tumors, Heidelberg, Germany
[5] Univ Heidelberg Hosp, Surg Clin, European Pancreas Ctr, Heidelberg, Germany
来源：
CELL RESEARCH | 2015年 / 25卷 / 08期
关键词：
T-CELLS; BLOCKADE; ANTIGENS; MELANOMA;
D O I：
10.1038/cr.2015.66
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The efficacy of cancer vaccines has long been hampered by insufficient definition of tumor-specific antigens. A recent study by Kreiter et al. published in Nature has provided a blueprint for a patient-tailored approach to develop individualized RNA vaccines.
引用
收藏
页码：887 / 888
页数：2
相关论文
共 50 条
  • [1] Cancer immunotherapy: exploiting neoepitopes
    Michael Platten
    Rienk Offringa
    Cell Research, 2015, 25 : 887 - 888
  • [2] Neoepitopes as cancer immunotherapy targets: key challenges and opportunities
    Brennick, Cory A.
    George, Mariam M.
    Corwin, William L.
    Srivastava, Pramod K.
    Ebrahimi-Nik, Hakimeh
    IMMUNOTHERAPY, 2017, 9 (04) : 361 - 371
  • [3] The double-edged sword of cancer mutations: exploiting neoepitopes for the fight against cancer
    Alvarado-Cruz, Isabel
    Meas, Rithy
    Paluri, Sesha Lakshmi Arathi
    Carufe, Kelly Estelle Wheeler
    Khan, Mohammed
    Sweasy, Joann Balazs
    MUTAGENESIS, 2020, 35 (01) : 69 - 77
  • [4] Exploiting bacteria for cancer immunotherapy
    Kwon, Seong-Young
    Ngo, Hien Thi-Thu
    Son, Jinbae
    Hong, Yeongjin
    Min, Jung-Joon
    NATURE REVIEWS CLINICAL ONCOLOGY, 2024, 21 (08) : 569 - 589
  • [5] Large-scale transcript variants dictate neoepitopes for cancer immunotherapy
    Ji, Shiliang
    Wang, Feifan
    Wu, Yongjie
    Hu, Haoran
    Xing, Zhen
    Zhu, Jie
    Xu, Shi
    Han, Tiyun
    Liu, Guilai
    Wu, Zengding
    Fei, Caiyi
    Kong, Lingming
    Chen, Jiangning
    Ding, Zhi
    Huang, Zhen
    Zhang, Junfeng
    SCIENCE ADVANCES, 2025, 11 (05):
  • [6] Exploiting innate immunity for cancer immunotherapy
    Yi, Ming
    Li, Tianye
    Niu, Mengke
    Mei, Qi
    Zhao, Bin
    Chu, Qian
    Dai, Zhijun
    Wu, Kongming
    MOLECULAR CANCER, 2023, 22 (01)
  • [7] Exploiting temporal aspects of cancer immunotherapy
    Zemek, Rachael M.
    Anagnostou, Valsamo
    Pires da Silva, Ines
    Long, Georgina V.
    Lesterhuis, Willem Joost
    NATURE REVIEWS CANCER, 2024, 24 (07) : 480 - 497
  • [8] Exploiting innate immunity for cancer immunotherapy
    Ming Yi
    Tianye Li
    Mengke Niu
    Qi Mei
    Bin Zhao
    Qian Chu
    Zhijun Dai
    Kongming Wu
    Molecular Cancer, 22
  • [9] Lost in the crowd: identifying targetable MHC class I neoepitopes for cancer immunotherapy
    Wilson, Eric A.
    Anderson, Karen S.
    EXPERT REVIEW OF PROTEOMICS, 2018, 15 (12) : 1065 - 1077
  • [10] The Cancer Epigenome: Exploiting Its Vulnerabilities for Immunotherapy
    Yau, Helen Loo
    Ettayebi, Ilias
    De Carvalho, Daniel D.
    TRENDS IN CELL BIOLOGY, 2019, 29 (01) : 31 - 43
12345